GlassScriptPhysician profile
Suzanne M Turner
NPI 1508120338
$2,991.06
in general payments reported to CMS, 2019-2025
12 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,573 · 2021: $249 · 2022: $380 · 2023: $78.76 · 2024: $367 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,378.30 | 2019 | |
| Alcon Vision LLC | $546.38 | 2019-2025 | Precision7, Total30, Precision 1 |
| Coopervision INC. | $208.96 | 2019-2022 | |
| Biotissue Holdings INC. | $155.82 | 2024 | |
| Eyevance Pharmaceuticals LLC | $140.64 | 2021 | |
| Abbvie INC. | $116.07 | 2025 | |
| Astellas Pharma US INC | $115.06 | 2024 | Izervay |
| Johnson & Johnson Surgical Vision, INC. | $87.99 | 2022 | |
| New World Medical,INC. | $78.18 | 2019 | |
| Glaukos Corporation | $71.25 | 2022 | |
| Rxsight INC | $54.38 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Bausch & Lomb Americas INC. | $38.03 | 2022-2023 | Infuse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.